HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC6A3
solute carrier family 6 member 3
Chromosome 5 Β· 5p15.33
NCBI Gene: 6531Ensembl: ENSG00000142319.20HGNC: HGNC:11049UniProt: Q01959
869PubMed Papers
1Diseases
0Drugs
18Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Highly Studied
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
dopamine transportaxonneuron projectionneuronal cell bodyParkinsonism-dystonia 1, infantile-onset
✦AI Summary

SLC6A3 encodes the dopamine transporter (DAT), which mediates sodium- and chloride-dependent reuptake of dopamine from synapses, playing a crucial role in dopaminergic neurotransmission. The transporter regulates dopamine levels by removing dopamine from the synaptic cleft, terminating dopaminergic signaling. SLC6A3 contains a 40-bp variable number tandem repeat (VNTR) polymorphism that has been extensively studied in neuropsychiatric disorders 1. Meta-analyses have revealed associations between specific SLC6A3 polymorphisms and personality disorders in European populations, particularly the 9-repeat allele variant 2. However, the relationship between SLC6A3 variants and schizophrenia remains inconsistent, with some studies showing associations with specific SNPs while others find no significant correlations 13. In ADHD research, differential associations have been observed between childhood and adult forms of the disorder, with the 9/9 genotype and 9-6 haplotype associated with persistent ADHD, contrasting with childhood ADHD patterns 4. Importantly, meta-analyses have failed to demonstrate significant associations between SLC6A3 VNTR polymorphisms and striatal dopamine transporter availability measured by SPECT imaging 5, suggesting the functional mechanisms underlying these genetic associations require further investigation.

Sources cited
1
SLC6A3 contains a 40-bp VNTR polymorphism and shows associations with schizophrenia risk factors
PMID: 31440993
2
9-repeat allele variant of rs28363170 is significantly associated with personality disorders in European populations
PMID: 39258346
3
No association found between SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in Han Chinese population
PMID: 25019689
4
9/9 genotype and 9-6 haplotype are associated with persistent ADHD, showing differential involvement compared to childhood ADHD
PMID: 19890261
5
Meta-analysis found no significant association between SLC6A3 VNTR and striatal dopamine transporter availability measured by SPECT
PMID: 21404331
Disease Associationsβ“˜1
Parkinsonism-dystonia 1, infantile-onsetUniProt
Pathogenic Variants18
NM_001044.5(SLC6A3):c.1269+1G>APathogenic
Classic dopamine transporter deficiency syndrome|not provided|Parkinsonism-dystonia, infantile
β˜…β˜…β˜†β˜†2022
NM_001044.5(SLC6A3):c.1762C>T (p.Arg588Ter)Pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2025β†’ Residue 588
NM_001044.5(SLC6A3):c.1708dup (p.Ala570fs)Likely pathogenic
Classic dopamine transporter deficiency syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 570
NM_001044.5(SLC6A3):c.1032-1G>CLikely pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2024
NM_001044.5(SLC6A3):c.341del (p.Phe114fs)Pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2024β†’ Residue 114
NM_001044.5(SLC6A3):c.1389C>A (p.Cys463Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 463
NM_001044.5(SLC6A3):c.1569_1592delinsA (p.Cys523_Phe531delinsTer)Pathogenic
Classic dopamine transporter deficiency syndrome
β˜…β˜†β˜†β˜†2023β†’ Residue 523
NM_001044.5(SLC6A3):c.1767+2T>CLikely pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2022
NM_001044.5(SLC6A3):c.1156G>A (p.Gly386Arg)Likely pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2021β†’ Residue 386
NM_001044.5(SLC6A3):c.892del (p.Tyr297_Leu298insTer)Pathogenic
Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2019β†’ Residue 297
NM_001044.5(SLC6A3):c.253C>T (p.Arg85Trp)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2019β†’ Residue 85
NM_001044.5(SLC6A3):c.1639dup (p.His547fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 547
NM_001044.5(SLC6A3):c.1031+1G>ALikely pathogenic
Classic dopamine transporter deficiency syndrome|Parkinsonism-dystonia, infantile
β˜…β˜†β˜†β˜†2017
NM_001044.5(SLC6A3):c.1398+5G>ALikely pathogenic
Classic dopamine transporter deficiency syndrome
β˜…β˜†β˜†β˜†2016
NM_001044.5(SLC6A3):c.1767+2_1767+3delLikely pathogenic
SLC6A3-related disorder
β˜†β˜†β˜†β˜†2024
NM_001044.5(SLC6A3):c.671T>C (p.Leu224Pro)Pathogenic
Classic dopamine transporter deficiency syndrome
β˜†β˜†β˜†β˜†2011β†’ Residue 224
NM_001044.5(SLC6A3):c.1184C>T (p.Pro395Leu)Pathogenic
Classic dopamine transporter deficiency syndrome
β˜†β˜†β˜†β˜†2009β†’ Residue 395
NM_001044.5(SLC6A3):c.1103T>A (p.Leu368Gln)Pathogenic
Classic dopamine transporter deficiency syndrome
β˜†β˜†β˜†β˜†2009β†’ Residue 368
View on ClinVar β†—
Related Genes
PRKNProtein interaction100%SNCAProtein interaction100%STX1AProtein interaction99%PRKCAProtein interaction98%COMTProtein interaction96%DBHProtein interaction96%
Tissue Expression

No tissue expression data available for this gene.

Gene Interaction Network
Click a node to explore
SLC6A3PRKNSNCASTX1APRKCACOMTDBH
PROTEIN STRUCTURE
Preparing viewer…
PDB9EO4 Β· 2.66 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.39Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.27 [0.19–0.39]
RankingsWhere SLC6A3 stands among ~20K protein-coding genes
  • #206of 20,598
    Most Researched869 Β· top 5%
  • #2,257of 5,498
    Most Pathogenic Variants18
  • #1,928of 17,882
    Most Constrained (LOEUF)0.39 Β· top quartile
Genes detectedSLC6A3
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.
PMID: 31440993
J Mol Neurosci Β· 2020
1.00
2
LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma.
PMID: 37628576
Genes (Basel) Β· 2023
0.92
3
Meta-analysis update of association between dopamine transporter SLC6A3 gene polymorphism and smoking cessation.
PMID: 27287604
J Health Psychol Β· 2018
0.90
4
DRD4 and SLC6A3 gene polymorphisms are associated with food intake and nutritional status in children in early stages of development.
PMID: 26350252
J Nutr Biochem Β· 2015
0.82
5
Genetic association of SLC6A3 (dopamine transporter) gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and meta-analysis.
PMID: 39258346
Psychiatr Genet Β· 2024
0.80